Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
14.04 EUR | +1.59% | -7.51% | +42.97% |
04-29 | Abivax: share price rises as two analysts express optimism | CF |
04-29 | Piper Sandler Starts Abivax With Overweight Rating, $42 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.97% | 930M | |
+23.73% | 48.09B | |
+47.41% | 40.62B | |
-3.08% | 40.43B | |
-6.20% | 28.36B | |
+7.64% | 24.89B | |
-19.22% | 19.01B | |
+29.70% | 12.09B | |
-0.71% | 11.88B | |
-0.04% | 11.8B |
- Stock Market
- Equities
- ABVX Stock
- News Abivax
- Abivax Gets US FDA Feedback, Guidance On Late-Stage Trial For Ulcerative Colitis Therapy